Label: CURATUSSIN- guaifenesin solution

  • NDC Code(s): 83335-101-04, 83335-101-08, 83335-101-16
  • Packager: Wittman Pharma, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated April 18, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Dosage & Admin

    Directions:

    ■ do not take more than 6 doses in any 24-hour period.

    AGEDOSE
    Adults & Children 12 years and over2-4 teaspoonfuls every 4 hours
    Children 6 years to under 12 years1-2 teaspoonfuls every 4 hours
    Children 2 to under 6 years

    1/2 - 1 teaspoonfuls every 4 hours
    Children Under 2 yearsAsk a Doctor

  • Warnings

    Warnings:

    Ask a doctor before use if you have

    ■ cough that occurs with too much phlegm (mucus)

    ■ cough that lasts or is chronic, such as occurs with smoking, asthma,

    Chronic bronchitis, or emphysema

    Stop use and ask a doctor if cough lasts more than 7 days, comes

    back, or is accompanied by fever, rash or persistent headache.

    These could be signs of a serious condition.

    If pregnant of breast-feeding, ask a health professional before

    use. Keep out of reach of children. In case of overdose, get

    medical help or contact a Poison Control Center right away.

  • INACTIVE INGREDIENT

    Inactive Ingredients: Citric Acid, Flavor, Methylparaben, Monoammonium Glycyrrhizinate, Potassium Citrate, Propylene Glycol, Propylparaben, Purified Water, Sorbitol, Sucralose

  • INDICATIONS & USAGE

    Uses:

    ■ helps loosen phlegm (mucus) and thin bronchial secretions to make

    coughs more productive

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get

    medical help or contact a Poison Control Center right away.

  • PURPOSE

    Purpose: Expectorant

  • ACTIVE INGREDIENT

    Active Ingredient (in each 5 mL tsp)

    Guaifenesin 100 mg

  • PRINCIPAL DISPLAY PANEL

    CuraTUSSIN Label

  • INGREDIENTS AND APPEARANCE
    CURATUSSIN 
    guaifenesin solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83335-101
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN100 mg  in 5 mL
    Inactive Ingredients
    Ingredient NameStrength
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    POTASSIUM CITRATE (UNII: EE90ONI6FF)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    AMMONIUM GLYCYRRHIZATE (UNII: 3VRD35U26C)  
    SORBITOL (UNII: 506T60A25R)  
    WATER (UNII: 059QF0KO0R)  
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorGRAPEImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:83335-101-16473 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/01/2024
    2NDC:83335-101-08237 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/01/2024
    3NDC:83335-101-04118 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/01/2024
    Image of Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01201/01/2024
    Labeler - Wittman Pharma, Inc. (830980947)
    Establishment
    NameAddressID/FEIBusiness Operations
    Wittman Pharma, Inc.830980947analysis(83335-101) , manufacture(83335-101) , label(83335-101)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!